Line 73: |
Line 73: |
| best results seem to occur with early treatment, | | best results seem to occur with early treatment, |
| although a 9-12 month trial is necessary to assess | | although a 9-12 month trial is necessary to assess |
− | the response in each case. Animals on ASIT | + | the response in each case. |
− | require careful supervision to control microbial
| + | |
− | infections and other flare factors, to administer
| |
− | anti-inflammatory treatment as required and to
| |
− | adjust the dose and/or frequency according
| |
− | to the clinical response (Figure 1).
| |
| The exact protocol varies widely but usually | | The exact protocol varies widely but usually |
| involves repeated injections a few days to 1-2 | | involves repeated injections a few days to 1-2 |
| weeks apart. Once the full dose is reached, the | | weeks apart. Once the full dose is reached, the |
| interval between injections can be extended. | | interval between injections can be extended. |
− | A rush protocol, where the initial loading course
| + | |
− | is given within a single day, was recently shown
| |
− | to be as effective as conventional ASIT in a small
| |
− | number of dogs (7). Recent reports also described
| |
− | starting with a full dose (monodose therapy).
| |
− | No adverse effects were seen in either case
| |
− | although the dogs were pre-medicated with
| |
− | an anti-histamine.
| |
− | Alum precipitated vaccines have a depot effect
| |
− | and require less frequent administration. Alum
| |
− | adjuvants potentiate IgE responses in experimental
| |
− | animals but no differences in efficacy between
| |
− | alum-precipitated and aqueous vaccines have been
| |
− | demonstrated in dogs. There are anecdotal reports
| |
− | of improved efficacy with low dose ASIT, but a
| |
− | controlled study, however, found no difference in
| |
− | efficacy between low dose and conventional
| |
− | alum-precipitated ASIT (8).
| |
| If ASIT proves successful, the interval between | | If ASIT proves successful, the interval between |
| injections can be extended. Increased pruritus | | injections can be extended. Increased pruritus |
Line 109: |
Line 88: |
| but most require maintenance injections every | | but most require maintenance injections every |
| 1-2 months. | | 1-2 months. |
− | Re-testing may reveal new sensitivities in dogs
| + | |
− | with initially negative tests, dogs <12 months
| |
− | old at the time of the original test, if there has
| |
− | been a poor response to ASIT or where a good
| |
− | response is not maintained. Re-formulating ASIT
| |
− | can be beneficial in these dogs.
| |
| Adverse effects are uncommon. Injection site | | Adverse effects are uncommon. Injection site |
| reactions and anaphylactic shock are very rare, | | reactions and anaphylactic shock are very rare, |
| although many dermatologists advise giving the | | although many dermatologists advise giving the |
− | first 5-6 doses in a veterinary clinic. Increased | + | first 5-6 doses in a veterinary clinic. |
− | pruritus after an injection indicates that the dose is
| |
− | too high although mild reactions can sometimes be
| |
− | managed with antihistamines.
| |
| | | |
| ===Anti-inflammatory therapy=== | | ===Anti-inflammatory therapy=== |